ChartMill · Sep 2, 2026
Which stocks have an unusual volume on Wednesday?
These stocks have an unusual volume in today's session
HK
NASDAQ · HKPD
Hong Kong Pharma Digital Technology Holdings Limited
Industrials · Integrated Freight & Logistics
$0.10
Down-$0.00 (-1.94%)
Updated Oct 7, 2026, 7:28 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 8.62M
- P/E ratio
- -299.74
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $1.72
- Volume
- 545.58K
- Avg. volume
- 166.7K
Price performance · HKPD
HKPD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
HKPD closed at $0.10 after 21 trading sessions, down 19.98% for the selected period.
- Last close
- $0.10
- Period change
- -19.98%
- Period low
- $0.10
- Period high
- $0.13
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $0.103 | $0.1072 | $0.10 | $0.1029 | 545.58K |
| Oct 5, 2026 | $0.11 | $0.11 | $0.1012 | $0.1036 | 2.67M |
| Oct 2, 2026 | $0.1091 | $0.1118 | $0.107 | $0.1095 | 259.84K |
| Oct 1, 2026 | $0.114 | $0.1159 | $0.108 | $0.1118 | 217.35K |
| Sep 30, 2026 | $0.11 | $0.1178 | $0.1052 | $0.116 | 649.29K |
| Sep 29, 2026 | $0.1064 | $0.1146 | $0.10 | $0.1103 | 513.54K |
| Sep 28, 2026 | $0.109 | $0.1137 | $0.1062 | $0.11 | 496.34K |
| Sep 25, 2026 | $0.118 | $0.1204 | $0.107 | $0.1118 | 564.98K |
| Sep 24, 2026 | $0.122 | $0.122 | $0.1153 | $0.1207 | 312.86K |
| Sep 23, 2026 | $0.1222 | $0.1222 | $0.115 | $0.1192 | 473.98K |
| Sep 22, 2026 | $0.1212 | $0.122 | $0.115 | $0.122 | 448.56K |
| Sep 21, 2026 | $0.1134 | $0.1224 | $0.1134 | $0.1212 | 335.41K |
| Sep 18, 2026 | $0.1208 | $0.124 | $0.1114 | $0.1135 | 716.42K |
| Sep 17, 2026 | $0.117 | $0.1249 | $0.1127 | $0.1223 | 1.49M |
| Sep 16, 2026 | $0.1075 | $0.1254 | $0.0961 | $0.1189 | 17.12M |
| Sep 15, 2026 | $0.1241 | $0.1242 | $0.105 | $0.1133 | 1.74M |
| Sep 14, 2026 | $0.125 | $0.125 | $0.1203 | $0.1249 | 1.14M |
| Sep 11, 2026 | $0.116 | $0.1293 | $0.1152 | $0.125 | 1.75M |
| Sep 10, 2026 | $0.1195 | $0.13 | $0.111 | $0.1206 | 56.33M |
| Sep 9, 2026 | $0.1299 | $0.1299 | $0.1238 | $0.1282 | 540.1K |
| Sep 8, 2026 | $0.1238 | $0.13 | $0.1238 | $0.1286 | 1.13M |
Latest HKPD news
The latest Smart Investors Daily articles mentioning HKPD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HKPD research
Overview
Company profile and research snapshot.
Company profile
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Jul 17, 2026
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened
Cellyan Biotechnology shares fell in after-hours trading after the company announced a Nasdaq listing compliance update.
Yahoo · Jul 16, 2026
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the “Notification Letter”) on July 14, 2026 from Nasdaq's Listing Qualifications Department indicating that the Company has been granted an additional 180 calendar day period, or until January 11, 2027, to regain c
Benzinga · Jul 16, 2026
Cellyan Biotechnology Granted 180‑Day Nasdaq Extension To Regain Compliance
Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
